account(Adds price increase in third paragraph.) April 15 (Bloomberg) -- Abbott Laboratories agreed to pay $52 million to resolve claims by direct drug buyers that it tried to harm competition when it quadrupled the price of its HIV medicine Norvir in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Agrees to Pay $52 Million to Resolve Aids Drug Case
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account